April 17, 2025
Proud to be an invited speaker for Epilepsy Grand Rounds Boston Children's Hospital, Harvard School of Medicine. Title: Targeting brain pH in the management of the pediatric epilepsies: Febrile Seizures and Infantile Epileptic Spasms
January 1, 1 2025
Dr. Morris Scantlebury has been appointed Scientific Director, Discovery (Basic) Science, of the Alberta Children's Hospital Research Institute. ACHRI Directors | Alberta Children’s Hospital Research Institute | University of Calgary
November 05, 2024:
Great news!!! Dr. Scantlebury and colleagues has been awarded a Proof-of Principal Grant to define biomarkers for treatment resistance and to test a probiotic treatment in patients with infantile spasms.
August 1, 2024:
Finally published!!!! Our paper describing mechanistic studies investigating the impact of inflammation on heat sensitive channels, breathing and seizures: Barrett KT, Roy A, Ebdalla A, Pittman QJ, Wilson RJA, Scantlebury MH. The Impact of Inflammation on Thermal Hyperpnea: Relevance for Heat Stress and Febrile Seizures. Am J Respir Cell Mol Biol. 2024 Aug;71(2):195-206. doi: 10.1165/rcmb.2023-0451OC. PMID: 38597725
February 21, 2024:
Blown away!!! Dr. Morris Scantlebury was selected for an ANSA Caribbean Excellence Award in Science and Technology: Dr. Morris Scantlebury - ANSA Awards Caribbean.
October 12th, 2023:
Honored!!! Dr. Morris Scantlebury was appointed Chair Scientific Research Committee of Epilepsy Canada. Leadership — Epilepsy Canada Epilepsi
March 1, 2022:
Fantastic News!!! Drs. Shearer (PI) and Scantlebury (Co-I) were awarded a grant to study how nutritional manipulation impacts seizures in a model of infantile spasms
July 15, 2021:
Great news!!!! Our laboratory was awarded a CIHR grant to study the role of acid sensing ion channels in infantile spasms. https://www.ucalgary.ca/news/cihr-project-grant-will-help-team-find-mechanisms-underlying-epilepsy-infants